INHERITED BONE MARROW FAILURE SYNDROME
Clinical trials for INHERITED BONE MARROW FAILURE SYNDROME explained in plain language.
Never miss a new study
Get alerted when new INHERITED BONE MARROW FAILURE SYNDROME trials appear
Sign up with your email to follow new studies for INHERITED BONE MARROW FAILURE SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope: drug combo after transplant may keep childhood leukemia at bay
Disease control Recruiting nowThis study tests whether giving two drugs (decitabine and filgrastim) after a stem cell transplant can safely prevent cancer from coming back in children and young adults with acute myeloid leukemia (AML), myelodysplastic syndromes (MDS), or related blood cancers. About 37 partic…
Matched conditions: INHERITED BONE MARROW FAILURE SYNDROME
Phase: PHASE2 • Sponsor: Franziska Wachter • Aim: Disease control
Last updated May 26, 2026 03:43 UTC
-
Could a cancer drug fix a bleeding disorder and lower leukemia risk?
Disease control Recruiting nowThis early-stage study tests the drug imatinib in adults with inherited RUNX1 gene mutations, which cause easy bleeding and a higher risk of blood cancers. The goal is to find the best dose that improves platelet function and reduces inflammation. Participants take imatinib daily…
Matched conditions: INHERITED BONE MARROW FAILURE SYNDROME
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 03:43 UTC
-
New study aims to catch rare cancers early in fanconi anemia patients
Knowledge-focused Recruiting nowThis study follows people with Fanconi anemia, a genetic condition that raises the risk of squamous cell carcinoma, especially in the mouth, throat, and genital areas. Researchers will screen 200 participants aged 12 and older (and some younger children with symptoms) every year …
Matched conditions: INHERITED BONE MARROW FAILURE SYNDROME
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated May 26, 2026 03:40 UTC
-
Can a simple genetic test catch blood cancers before they start?
Knowledge-focused Recruiting nowThis study uses advanced genetic testing (next generation sequencing) to look for early warning signs of pre-myeloid cancers and bone marrow failure in 2000 people. Participants have certain blood abnormalities or genetic markers that may increase their risk. The goal is to bette…
Matched conditions: INHERITED BONE MARROW FAILURE SYNDROME
Phase: NA • Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated May 18, 2026 12:07 UTC